These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38572510)

  • 41. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications.
    Yang J; Luly KM; Green JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1853. PubMed ID: 36193561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System.
    Kuplennik N; Lang K; Steinfeld R; Sosnik A
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39633-39647. PubMed ID: 31532618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain.
    Zha S; Wong KL; All AH
    Adv Healthc Mater; 2022 Jun; 11(11):e2102610. PubMed ID: 35166052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nano-ART and NeuroAIDS.
    Das MK; Sarma A; Chakraborty T
    Drug Deliv Transl Res; 2016 Oct; 6(5):452-72. PubMed ID: 27137528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
    Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.
    Rao KS; Reddy MK; Horning JL; Labhasetwar V
    Biomaterials; 2008 Nov; 29(33):4429-38. PubMed ID: 18760470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.
    Li J; Feng L; Fan L; Zha Y; Guo L; Zhang Q; Chen J; Pang Z; Wang Y; Jiang X; Yang VC; Wen L
    Biomaterials; 2011 Jul; 32(21):4943-50. PubMed ID: 21470674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions.
    You Q; Sokolov M; Grigartzik L; Hintz W; van Wachem BGM; Henrich-Noack P; Sabel BA
    Mol Pharm; 2019 Dec; 16(12):5068-5075. PubMed ID: 31609624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
    Porru M; Zappavigna S; Salzano G; Luce A; Stoppacciaro A; Balestrieri ML; Artuso S; Lusa S; De Rosa G; Leonetti C; Caraglia M
    Oncotarget; 2014 Nov; 5(21):10446-59. PubMed ID: 25431953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoparticle-mediated delivery of oligonucleotides to the blood-brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms.
    Ko YT
    J Drug Target; 2013 Nov; 21(9):866-73. PubMed ID: 23952765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo.
    Fu L; Shi B; Wen S; Morsch M; Wang G; Zhou Z; Mi C; Sadraeian M; Lin G; Lu Y; Jin D; Chung R
    Acta Biomater; 2022 Jul; 147():403-413. PubMed ID: 35605956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
    Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.